Literature DB >> 28198210

A Minority of Patients Newly Diagnosed with AIDS Are Started on Antiretroviral Therapy at the Time of Diagnosis in a Large Public Hospital in the Southeastern United States.

Neela D Goswami1,2, Jonathan Colasanti1, Jonathan J Khoubian1, Yijian Huang3, Wendy S Armstrong1, Carlos Del Rio1,4.   

Abstract

Prompt antiretroviral therapy (ART) initiation after AIDS diagnosis, in the absence of certain opportunistic infections such as tuberculosis and cryptococcal meningitis, delays disease progression and death, but system barriers to inpatient ART initiation at large hospitals in the era of modern ART have been less studied. We reviewed hospitalizations for persons newly diagnosed with AIDS at Grady Memorial Hospital in Atlanta, Georgia in 2011 and 2012. Individual- and system-level variables were collected. Logistic regression models were used to estimate the odds ratios (ORs) for ART initiation prior to discharge. With Georgia Department of Health surveillance data, we estimated time to first clinic visit, ART initiation, and viral suppression. In the study population (n = 81), ART was initiated prior to discharge in 10 (12%) patients. Shorter hospital stay was significantly associated with lack of ART initiation at the time of HIV diagnosis (8 versus 24 days, OR: 1.14, 95% confidence interval: 1.04-1.25). Reducing barriers to ART initiation for newly diagnosed HIV-positive patients with short hospital stays may improve time to viral suppression.

Entities:  

Keywords:  antiretroviral initiation; hospitalized; inpatient; system barriers

Mesh:

Substances:

Year:  2017        PMID: 28198210      PMCID: PMC6192024          DOI: 10.1177/2325957417692679

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  17 in total

Review 1.  When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!

Authors:  Philip M Grant; Andrew R Zolopa
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 2.  HIV/AIDS in the Southern USA: a disproportionate epidemic.

Authors:  Susan S Reif; Kathryn Whetten; Elena R Wilson; Carolyn McAllaster; Brian W Pence; Sara Legrand; Wenfeng Gong
Journal:  AIDS Care       Date:  2013-08-14

3.  The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.

Authors:  Elvin H Geng; James S Kahn; Olivia C Chang; C Bradley Hare; Katerina A Christopoulos; Diane Jones; Maya L Petersen; Steven G Deeks; Diane V Havlir; Monica Gandhi
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

4.  Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.

Authors:  L Deconinck; Y Yazdanpanah; R J Gilson; H Melliez; N Viget; V Joly; C A Sabin
Journal:  HIV Med       Date:  2014-12-18       Impact factor: 3.180

5.  Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color.

Authors:  Lynne C Messer; E Byrd Quinlivan; Heather Parnell; Katya Roytburd; Adaora A Adimora; Natasha Bowditch; Nancy DeSousa
Journal:  AIDS Patient Care STDS       Date:  2013-07       Impact factor: 5.078

6.  Location of HIV diagnosis impacts linkage to medical care.

Authors:  Baligh R Yehia; Elizabeth Ketner; Florence Momplaisir; Alisa J Stephens-Shields; Nadia Dowshen; Michael G Eberhart; Kathleen A Brady
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

7.  Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.

Authors:  Demilade A Adedinsewo; Stanley C Wei; McKaylee Robertson; Charles Rose; Christopher H Johnson; Julie Dombrowski; Jacek Skarbinski
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

8.  Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011.

Authors:  Ling Chin Hsu; Hong-Ha M Truong; Eric Vittinghoff; Qi Zhi; Susan Scheer; Sandra Schwarcz
Journal:  J Infect Dis       Date:  2013-11-11       Impact factor: 5.226

9.  Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.

Authors:  S Crystal; U Sambamoorthi; P J Moynihan; E McSpiritt
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

10.  Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Authors:  Andrew Zolopa; Janet Andersen; William Powderly; Alejandro Sanchez; Ian Sanne; Carol Suckow; Evelyn Hogg; Lauren Komarow
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.